485 related articles for article (PubMed ID: 17888516)
21. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Buckley PF; Paulsson B; Brecher M
J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
[TBL] [Abstract][Full Text] [Related]
22. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.
Sachs G; Chengappa KN; Suppes T; Mullen JA; Brecher M; Devine NA; Sweitzer DE
Bipolar Disord; 2004 Jun; 6(3):213-23. PubMed ID: 15117400
[TBL] [Abstract][Full Text] [Related]
23. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
Bowden CL
J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
[TBL] [Abstract][Full Text] [Related]
24. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
[TBL] [Abstract][Full Text] [Related]
25. Key treatment studies of lithium in manic-depressive illness: efficacy and side effects.
Bowden CL
J Clin Psychiatry; 1998; 59 Suppl 6():13-9; discussion 20. PubMed ID: 9674932
[TBL] [Abstract][Full Text] [Related]
26. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.
Calabrese JR; Shelton MD; Rapport DJ; Youngstrom EA; Jackson K; Bilali S; Ganocy SJ; Findling RL
Am J Psychiatry; 2005 Nov; 162(11):2152-61. PubMed ID: 16263857
[TBL] [Abstract][Full Text] [Related]
27. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
Bowden CL; Collins MA; McElroy SL; Calabrese JR; Swann AC; Weisler RH; Wozniak PJ
Neuropsychopharmacology; 2005 Oct; 30(10):1932-9. PubMed ID: 15956987
[TBL] [Abstract][Full Text] [Related]
28. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
29. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
Adler CM; Fleck DE; Brecher M; Strakowski SM
J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
[TBL] [Abstract][Full Text] [Related]
30. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
[TBL] [Abstract][Full Text] [Related]
31. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
[TBL] [Abstract][Full Text] [Related]
32. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
[TBL] [Abstract][Full Text] [Related]
33. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).
Weisler RH; Nolen WA; Neijber A; Hellqvist A; Paulsson B;
J Clin Psychiatry; 2011 Nov; 72(11):1452-64. PubMed ID: 22054050
[TBL] [Abstract][Full Text] [Related]
34. Plasma GABA predicts acute response to divalproex in mania.
Petty F; Rush AJ; Davis JM; Calabrese JR; Kimmel SE; Kramer GL; Small JG; Miller MJ; Swann AE; Orsulak PJ; Blake ME; Bowden CL
Biol Psychiatry; 1996 Feb; 39(4):278-84. PubMed ID: 8645774
[TBL] [Abstract][Full Text] [Related]
35. Divalproex extended-release in acute bipolar II depression.
Wang PW; Nowakowska C; Chandler RA; Hill SJ; Nam JY; Culver JL; Keller KL; Ketter TA
J Affect Disord; 2010 Jul; 124(1-2):170-3. PubMed ID: 19923006
[TBL] [Abstract][Full Text] [Related]
36. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
37. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Ketter TA
J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
[TBL] [Abstract][Full Text] [Related]
38. Report on efficacy of treatments for bipolar disorder.
Gelenberg AJ; Hopkins HS
Psychopharmacol Bull; 1993; 29(4):447-56. PubMed ID: 8084977
[TBL] [Abstract][Full Text] [Related]
39. Divalproex in the treatment of bipolar disorder.
Keck PE; McElroy SL
Psychopharmacol Bull; 2003; 37 Suppl 2():67-73. PubMed ID: 15021862
[TBL] [Abstract][Full Text] [Related]
40. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
McElroy SL; Keck PE; Stanton SP; Tugrul KC; Bennett JA; Strakowski SM
J Clin Psychiatry; 1996 Apr; 57(4):142-6. PubMed ID: 8601548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]